quinacrine has been researched along with Hypertrophy, Right Ventricular in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veeroju, S | 1 |
| Mamazhakypov, A | 1 |
| Rai, N | 1 |
| Kojonazarov, B | 1 |
| Nadeau, V | 1 |
| Breuils-Bonnet, S | 1 |
| Li, L | 1 |
| Weissmann, N | 1 |
| Rohrbach, S | 1 |
| Provencher, S | 1 |
| Bonnet, S | 1 |
| Seeger, W | 1 |
| Schermuly, R | 1 |
| Novoyatleva, T | 1 |
1 other study available for quinacrine and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Effect of p53 activation on experimental right ventricular hypertrophy.
Topics: Adult; Aged; Animals; Cells, Cultured; Endothelial Cells; Fatty Acids; Female; Fibroblasts; Heme Oxy | 2020 |